UnitedHealth Group Incorporated $UNH Shares Sold by Harbor Investment Advisory LLC

Harbor Investment Advisory LLC reduced its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 25.5% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 20,358 shares of the healthcare conglomerate’s stock after selling 6,986 shares during the period. Harbor Investment Advisory LLC’s holdings in UnitedHealth Group were worth $7,030,000 at the end of the most recent quarter.

A number of other institutional investors also recently bought and sold shares of the business. North Capital Inc. raised its holdings in shares of UnitedHealth Group by 16.2% during the third quarter. North Capital Inc. now owns 194 shares of the healthcare conglomerate’s stock worth $67,000 after purchasing an additional 27 shares during the last quarter. Sunflower Bank N.A. boosted its position in UnitedHealth Group by 1.5% in the 3rd quarter. Sunflower Bank N.A. now owns 1,916 shares of the healthcare conglomerate’s stock worth $662,000 after purchasing an additional 28 shares in the last quarter. Axis Wealth Partners LLC boosted its holdings in UnitedHealth Group by 1.7% during the third quarter. Axis Wealth Partners LLC now owns 1,631 shares of the healthcare conglomerate’s stock worth $563,000 after buying an additional 28 shares in the last quarter. Abound Wealth Management raised its position in shares of UnitedHealth Group by 13.5% in the third quarter. Abound Wealth Management now owns 244 shares of the healthcare conglomerate’s stock worth $84,000 after acquiring an additional 29 shares during the period. Finally, Western Pacific Wealth Management LP raised its holdings in UnitedHealth Group by 12.0% in the 2nd quarter. Western Pacific Wealth Management LP now owns 336 shares of the healthcare conglomerate’s stock worth $105,000 after purchasing an additional 36 shares during the period. 87.86% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of research analysts have recently issued reports on UNH shares. Royal Bank Of Canada increased their target price on UnitedHealth Group from $286.00 to $408.00 and gave the company an “outperform” rating in a research report on Wednesday, October 29th. Jefferies Financial Group upped their price target on shares of UnitedHealth Group from $317.00 to $409.00 and gave the stock a “buy” rating in a research report on Friday, October 17th. UBS Group raised their target price on UnitedHealth Group from $378.00 to $430.00 and gave the company a “buy” rating in a research report on Wednesday, October 29th. Piper Sandler dropped their target price on shares of UnitedHealth Group from $423.00 to $417.00 and set an “overweight” rating for the company in a report on Tuesday, October 28th. Finally, Mizuho upped their price objective on shares of UnitedHealth Group from $300.00 to $430.00 and gave the company an “outperform” rating in a research note on Thursday, October 9th. One equities research analyst has rated the stock with a Strong Buy rating, seventeen have given a Buy rating, nine have issued a Hold rating and three have issued a Sell rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $385.75.

Trending Headlines about UnitedHealth Group

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: Brokerages maintain a constructive stance — analysts on average rate UNH a “Moderate Buy,” which supports baseline investor confidence in the business despite headline risk. UnitedHealth Group Incorporated (NYSE:UNH) Given Average Rating of “Moderate Buy” by Brokerages
• Positive Sentiment: Company-funded independent studies (Milliman) claim Medicare Advantage delivers cost savings for the federal government and lower out-of-pocket costs for beneficiaries — a message UnitedHealth is using to defend its MA business model. New Independent Studies: Medicare Advantage Delivers Greater Value to the Federal Government and Beneficiaries than Traditional Medicare
• Positive Sentiment: Market participants and commentators continue to include UNH among healthcare names to watch, reflecting confidence in its scale and membership/margin drivers over the medium term. Final Trades: Capital One, UnitedHealth, Regeneron and Alibaba
• Neutral Sentiment: Sector commentary (healthcare ETFs, MarketBeat) highlights a broader healthcare rebound — a positive backdrop for UNH but not a direct counter to regulatory headlines. This ETF Is Proof That the Healthcare Rebound Is Real (UNH)
• Neutral Sentiment: Post-Q3 coverage and analyst pieces review UNH’s earnings beat and growth profile; fundamentals remain strong but may be overshadowed by policy risk. UnitedHealth (UNH): Buy, sell, or hold post Q3 earnings?
• Negative Sentiment: Senate report and press coverage allege UnitedHealth used aggressive tactics to gather diagnoses that boost Medicare Advantage payments — the primary driver of today’s negative sentiment as it raises risks of fines, repayment, or tighter oversight. Senate report says UnitedHealth used aggressive tactics to boost medicare payments, WSJ reports
• Negative Sentiment: Separate scrutiny over nursing-home practices adds another regulatory/legal angle investors must monitor, increasing uncertainty around reputational and compliance costs. UnitedHealth faces renewed scrutiny into its nursing home practices. What does that mean for UNH stock?

UnitedHealth Group Stock Down 1.0%

Shares of UNH opened at $340.64 on Tuesday. UnitedHealth Group Incorporated has a 12-month low of $234.60 and a 12-month high of $606.36. The firm has a market cap of $308.57 billion, a P/E ratio of 17.78, a price-to-earnings-growth ratio of 2.08 and a beta of 0.42. The company’s 50-day moving average price is $329.65 and its 200 day moving average price is $321.60. The company has a current ratio of 0.82, a quick ratio of 0.82 and a debt-to-equity ratio of 0.71.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, October 28th. The healthcare conglomerate reported $2.92 earnings per share for the quarter, topping analysts’ consensus estimates of $2.87 by $0.05. The firm had revenue of $113.16 billion during the quarter, compared to analysts’ expectations of $113.19 billion. UnitedHealth Group had a net margin of 4.04% and a return on equity of 19.23%. The firm’s quarterly revenue was up 12.2% on a year-over-year basis. During the same quarter last year, the company posted $7.15 EPS. On average, sell-side analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, December 16th. Shareholders of record on Monday, December 8th were issued a dividend of $2.21 per share. The ex-dividend date was Monday, December 8th. This represents a $8.84 dividend on an annualized basis and a yield of 2.6%. UnitedHealth Group’s dividend payout ratio is 46.14%.

UnitedHealth Group Company Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.